A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Clinical trial NCT05810038 · COMPLETED
Trial details
- NCT number
- NCT05810038
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2025-08-25
- Enrollment
- 787
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.